Adding MRI-targeted biopsy leads to more reliable diagnosis of aggressive prostate cancer
BALTIMORE, MD – March 4, 2020 – Using a combination of magnetic resonance imaging (MRI) to target and sample suspicious prostate tissue along with a standard prostate biopsy is significantly more likely to detect the most aggressive prostate cancers than standard biopsy alone. This finding, published today in the New England Journal of Medicine, could…